Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-11-24
pubmed:abstractText
Clinical data underscores the fact that subsequent high mortality rates occur in patients who survive acute septic episodes. Herein, we described a clinically relevant model of experimental sepsis that we believe will allow further investigation of the manner in which the pulmonary innate immune response is modulated after sepsis. C57BL/6 mice were subjected to cecal ligation and puncture (CLP) model, whereby the cecum was partially ligated and punctured nine times with a 21-gauge needle. This procedure was associated with 100% mortality at 3 days after surgery. In contrast, when mice subjected to CLP were treated with antibiotic beginning at 8 hours after surgery, and every 12 hours thereafter until 3 days, approximately 60% of the mice survived. Interestingly, CLP survivors quickly succumbed (100% mortality) to pulmonary infection when intratracheally challenged, at day 3 after CLP, with viable Aspergillus fumigatus conidia. No mortality was observed in conidia-challenged sham-operated mice. The defective innate immune response against A. fumigatus in CLP mice could not be explained by a failure of neutrophils to infiltrate the lungs. Instead, gene array analysis revealed that several components of the innate immune response, including the nuclear factor-kappaB signaling pathway, were down-regulated. Thus, we describe a system of sepsis-induced innate immune failure in the lungs of C57BL/6 mice.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-10623846, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-10816537, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-10878372, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-10882600, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11035713, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11055602, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11175800, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11204137, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11208651, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11514221, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11859143, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-11957017, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-12009573, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-12065501, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-12165529, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-12524386, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-12540571, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-12700374, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-1548046, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-1848979, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-1889276, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-1949183, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-2803749, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-6879447, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-7510665, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-7609265, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-8890233, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-9091694, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-9185504, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-942051, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-9886412, http://linkedlifedata.com/resource/pubmed/commentcorrection/14633632-9973423
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
163
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2605-17
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:14633632-Animals, pubmed-meshheading:14633632-Anti-Bacterial Agents, pubmed-meshheading:14633632-Aspergillosis, pubmed-meshheading:14633632-Aspergillus fumigatus, pubmed-meshheading:14633632-Bacterial Infections, pubmed-meshheading:14633632-Cell Movement, pubmed-meshheading:14633632-Chemokines, pubmed-meshheading:14633632-Cytokines, pubmed-meshheading:14633632-Disease Susceptibility, pubmed-meshheading:14633632-Down-Regulation, pubmed-meshheading:14633632-Female, pubmed-meshheading:14633632-Leukocytes, pubmed-meshheading:14633632-Lung, pubmed-meshheading:14633632-Lung Diseases, Fungal, pubmed-meshheading:14633632-Mice, pubmed-meshheading:14633632-Mice, Inbred C57BL, pubmed-meshheading:14633632-Monocytes, pubmed-meshheading:14633632-NF-kappa B, pubmed-meshheading:14633632-Neutrophil Infiltration, pubmed-meshheading:14633632-Peritoneal Cavity, pubmed-meshheading:14633632-Peritonitis, pubmed-meshheading:14633632-Severity of Illness Index, pubmed-meshheading:14633632-Survival Analysis
pubmed:year
2003
pubmed:articleTitle
Septic mice are susceptible to pulmonary aspergillosis.
pubmed:affiliation
Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109-0602, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't